Dengue NS1 and prM antibodies increase the sensitivity of acute dengue diagnosis test and differentiate from Japanese encephalitis infection

Journal of Immunological Methods

Volumn 407, Issue , 2014, Pages 116-119

  Gowri Sankar, S ^a   Balaji, T ^b   Venkatasubramani, K ^b   Thenmozhi, V ^b   Dhananjeyan, K J ^b   Paramasivan, R ^b   Tyagi, B K ^b   John Vennison, S ^a  

^a Department of Biotechnology Anna University BIT Campus ^*  (India)

^b INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

Author keywords

Antigen detection; Cross reactivity; Dengue virus (DENV); Flavi virus detection; Japanese encephalitis virus (JEV); Serological differentiation

Indexed keywords

IMMUNOGLOBULIN; NONSTRUCTURAL PROTEIN 1; PRE MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ARTICLE; CONVALESCENCE; CROSS REACTION; DENGUE; DENGUE VIRUS; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLAVIVIRUS; GOLD STANDARD; JAPANESE ENCEPHALITIS; JAPANESE ENCEPHALITIS VIRUS; LABORATORY DIAGNOSIS; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEROLOGY; VIRUS DETECTION;

DENGUE VIRUS; FLAVIVIRUS; JAPANESE ENCEPHALITIS VIRUS;

ANTIGEN DETECTION; CROSS REACTIVITY; DENGUE VIRUS (DENV); FLAVI VIRUS DETECTION; JAPANESE ENCEPHALITIS VIRUS (JEV); SEROLOGICAL DIFFERENTIATION;

ANTIBODIES, VIRAL; CROSS REACTIONS; DENGUE; DENGUE VIRUS; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC TESTS, ROUTINE; DISEASE PROGRESSION; EARLY DIAGNOSIS; ENCEPHALITIS, JAPANESE; HUMANS; INDIA; SENSITIVITY AND SPECIFICITY; VIRAL NONSTRUCTURAL PROTEINS; VIRAL PROTEINS;

EID: 84901447021     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2014.03.028     Document Type: Article

References (22)

1. Allwinn R., Doerr H.W., Emmerich P., Schmitz H., Preiser W. Cross reactivity in flavivirus serology: new implications of an old findings. Med. Microbiol. Immunol. 2002, 190:199-202.
2. Anderson K.B., Gibbons R.V., Thomas S.J., Rothman A.L., Nisalak A., Berkelman R.L., Libraty D.H., Endy T.P. Preexisting Japanese encephalitis virus neutralizing antibodies and increased symptomatic dengue illness in a school-based cohort in Thailand. PLoS Negl. Trop. Dis. 2011, 5:e1311.
3. Cardosa M.J., Wang S.M., Sum M.S.H., Tio P.H. Antibodies against prM protein distinguish between previous infection with dengue and Japanese encephalitis viruses. BMC Microbiol. 2002, 2:9.
4. Houghton-Trivino N., Montana D., Castellanos J. Dengue-yellow fever sera cross-reactivity; challenges for diagnosis. Rev. Salud Publ. 2008, 10:299-307.
5. Hua R., Chen N., Qin C., et al. Identification and characterization of a virus-specific continuous B-cell epitope on the prM/M protein of Japanese encephalitis virus: potential applications in the detection of antibodies to distinguish Japanese encephalitis virus infection from west nile virus and dengue virus infections. Virol. J. 2010, 7:249.
6. Huang J.L., Huang J.H., Shyu R.H., Terng C.W., Lin Y.L., Kuo M.D., Yao C.W., Shaio M.F. High level expression of recombinant dengue virus NS1 protein and its potential use as a diagnostic antigen. J. Med. Virol. 2001, 65:553-560.
7. Kimura-Kuroda J., Yasui K. Antigenic comparison of envelope protein E between Japanese encephalitis virus and some other flaviviruses using monoclonal antibodies. J. Gen. Virol. 1986, 67:2663-2672.
8. Koraka P., Zeller H., Niedrig M., Osterhaus A.D., Graen J. Reactivity of serum samples from patients with a flavivirus infection measured by immunofluorescence assays and ELISA. Microbes Infect. 2002, 46:1209-1215.
9. Kuno G. Serodiagnosis of flaviviral infections and vaccinations in humans. Adv. Virus Res. 2003, 61:3-65.
10. Kyle J.L., Harris E. Global spread and persistence of dengue. Annu. Rev. Microbiol. 2008, 62:71-92.
11. Lanciotti R.S., Calisher C.H., Gubler D.J., Chang G.J., Vordam A.V. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J. Clin. Microbiol. 1992, 30:545-551.
12. Lazaro-Olan L., Mellado-Sanchez G., Garcia-Cordero J., Escobar-Gutierrez A., Santos-Argumedo L., Gutierrez-Castaneda B., Cedillo-Barron L. Analysis of antibody response in human dengue patients from the Mexican coast using recombinant antigens. Vec. Borne. Zoo. Dis. 2008, 8:69-79.
13. Lemes E.M.B., Miagostovicsh M.P., Alves A.M.B., Costa S.M., Fillipis A.M.B., Aroma G.R.G., Araujo M.A.V. Circulating human antibodies against dengue NS1 protein: potential of recombinant D2V-NS1 proteins in diagnostic tests. J. Clin. Virol. 2005, 32:305-312.
14. Makino Y., Tadano M., Saito M., Maneekarn N., Sittisombut N., Sirisantahna N.V., Poneprasert B., Fukunaga T. Studies on serological cross-reaction in sequential flavivirus infections. Microbiol. Immunol. 1994, 38:951-955.
15. Martin D.A., Biggerstaff B.J., Allen B., Johnson A.J., Lanciotti R.S., Roehrig J.T. Use of immunoglobulin M cross-reaction in differential diagnosis of human flaviviral encephalitis infections in the Unites States. Clin. Vaccine. Immunol. 2002, 9:544-549.
16. Mclean R.G., Ubico S.R., Bourne D., Komar N. West nile virus in livestock and wild life. Curr. Top. Microbiol. Immunol. 2002, 267:271-308.
17. Oceguera L.F., Patiris P.J., Chiles R.E., Busch M.P., Tobler L.H., Hanson C.V. Flavivirus serology by Western blot analysis. Am. J. Trop. Med. Hyg. 2007, 77:159-163.
18. Sankar S.G., Dhananjeyan K.J., Paramasivan R., Thenmozhi V., Tyagi B.K., Vennison S.J. Evaluation and use of NS1 IgM antibody detection for acute dengue virus diagnosis: report from an outbreak investigation. Clin. Microbiol. Infect. 2012, 12:E8-E10.
19. Stadler K., Allison S.L., Schalich J., Heinz F.X. Proteolytic activation of tick borne encephalitis virus by furin. J. Virol. 1997, 71:8475-8481.
20. Tesh R.B., Travassos de Rosa P.A.A., Guzman H., Araujo T.P., Xiao S.Y. Immunization with heterologous flaviviruses protective against fatal West Nile encephalitis. Emerg. Infect. Dis. 2002, 8:245-251.
21. Valdes K., Alvarez M., Pupo M., Vazquez S., Rodriguez R., Guzman M.G. Human dengue antibodies against structural and nonstructural proteins. Clin. Diagn. Lab. Immunol. 2000, 7:856-857.
22. WHO recommended standards for surveillance of selected vaccine-preventable disease 2006, WHO, Geneva.